Literature DB >> 11707561

Obesity and disease management: effects of weight loss on comorbid conditions.

J W Anderson1, E C Konz.   

Abstract

OBJECTIVE: This review is designed to quantitate the effects of obesity and weight gain on risk for coronary heart disease (CHD) and to review the effects of weight loss on CHD risk factors. RESEARCH METHODS AND PROCEDURES: After a comprehensive review of the literature related to body weight and weight gain on CHD risk, the relative risks (RRs) were tabulated. Values were averaged and meta-analysis techniques were used to estimate the variance-adjusted RR.
RESULTS: Young persons with higher body mass index values have a significantly higher risk for CHD than do slender young people. For every 1% above a desirable body mass index, the risk for CHD increases by 3.3% for women and by 3.6% for men. Every kilogram of weight gain after high school increases risk for CHD by 5.7% for women and 3.1% for men. Weight loss significantly decreases major CHD risk factors. For every kilogram of weight loss the following favorable changes occur: fasting serum cholesterol, -1.0%; low-density lipoprotein cholesterol, -0.7%; triglycerides, -1.9%; high-density lipoprotein cholesterol, +0.2%; systolic blood pressure, -0.5%; diastolic blood pressure, -0.4%; and blood glucose, -0.2 mM. DISCUSSION: Obesity and/or weight gain are associated with major risk for CHD. Weight loss significantly improves serum lipid parameters, blood pressure, and fasting blood glucose values. Effective treatment approaches are available for most overweight or obese individuals but a major challenge is to enable these individuals to engage in these programs. Professional and consumer education is essential for advancing effective intervention strategies for overweight individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707561     DOI: 10.1038/oby.2001.138

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  56 in total

1.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 2.  The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.

Authors:  P C Manoria; H K Chopra; S K Parashar; A L Dutta; Brian Pinto; Ajit Mullasari; Samir Prajapati
Journal:  Indian Heart J       Date:  2013-11-25

3.  Prevalence and determinants of hyperlipidemia in moderate altitude areas of the Yunnan-Kweichow plateau in Southwestern China.

Authors:  Bingjun Deng; Tingguang Luo; Yanfei Huang; Tianhang Shen; Jing Ma
Journal:  High Alt Med Biol       Date:  2012-03       Impact factor: 1.981

4.  Up to 7 Years of Sustained Weight Loss for Weight-Loss Program Completers.

Authors:  Nia S Mitchell; Sarit Polsky; Victoria A Catenacci; Anna L Furniss; Allan V Prochazka
Journal:  Am J Prev Med       Date:  2015-05-30       Impact factor: 5.043

5.  Primary Care Patients' and Providers' Perspectives about an Online Weight Management Program: a Qualitative Study.

Authors:  Ronen Rozenblum; Barbara A De La Cruz; Nyryan V Nolido; Ihorma Adighibe; Kristina Secinaro; Katherine D McManus; Florencia Halperin; Jason P Block; David W Bates; Heather J Baer
Journal:  J Gen Intern Med       Date:  2019-05-31       Impact factor: 5.128

6.  Metabolic syndrome and weight gain in adulthood.

Authors:  Dawn E Alley; Virginia W Chang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-11-11       Impact factor: 6.053

Review 7.  What is the best size descriptor to use for pharmacokinetic studies in the obese?

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

8.  Development of a dosing strategy for enoxaparin in obese patients.

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

9.  Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Paul Muntner; Amanda Anderson; Jeanne Charleston; Zhen Chen; Virginia Ford; Gail Makos; Andrew O'Connor; Kalyani Perumal; Mahboob Rahman; Susan Steigerwalt; Valerie Teal; Raymond Townsend; Matthew Weir; Jackson T Wright
Journal:  Am J Kidney Dis       Date:  2009-12-05       Impact factor: 8.860

10.  Nutrigenomic analysis of diet-gene interactions on functional supplements for weight management.

Authors:  Francis C Lau; Manashi Bagchi; Chandan Sen; Sashwati Roy; Debasis Bagchi
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.